SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-036789
Filing Date
2023-08-02
Accepted
2023-08-02 08:15:12
Documents
15
Period of Report
2023-07-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20230728.htm   iXBRL 8-K 66595
2 EX-10.1 tlis-ex10_1.htm EX-10.1 35515
3 EX-99.1 tlis-ex99_1.htm EX-99.1 15458
4 GRAPHIC img150164034_0.jpg GRAPHIC 3828
  Complete submission text file 0000950170-23-036789.txt   258053

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlis-20230728_lab.xml EX-101.LAB 13904
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlis-20230728.xsd EX-101.SCH 2462
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlis-20230728_pre.xml EX-101.PRE 11432
9 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20230728_htm.xml XML 4896
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 231133802
SIC: 3826 Laboratory Analytical Instruments